Pharmacist.com | Publications

2010 International Pharmaceutical Federation PSWC and AAPS Annual
Meeting

›› Call for One-to-One Nominations

›› August 25, 2010 - Legislative and Regulatory Update Restricted

›› Corrected Version: August 11, 2010 - Legislative and Regulatory Update Restricted

›› July 28, 2010 - Legislative and Regulatory Update Restricted

›› July 14, 2010 - Legislative and Regulatory Update Restricted

Pharmacy Today

›› Suspicious supplements – Dietary supplements and drugs: Different regulations, but similar quality issues

›› Medications without borders – An increasingly complex supply chain leads to new challenges for FDA

›› Empty shelves: Med recalls creating questions – Quality breaches not new, but different

›› Developing your practice to support a resident

Student Pharmacist

›› Living the non-traditional life

›› Impressions of other health professionals and collaboration

›› The young and the restless

Transitions

›› Mentoring Future Pharmacy Leaders Yields Abundant Rewards

›› Balance Your Personal and Professional Lives Online

›› Just Life: Road Trip!

Books & Electronic Products

›› Book of the month - Handbook of Basic Pharmacokinetics

›› Preview the articles to be published in the second edition of Pharmacy: An Introduction to the Profession

Featured Books
›› Public Relations for Pharmacists
›› Essentials of Cultural Competence in Pharmacy Practice
›› Pharmacy Practice Experiences: A Student’s Handbook

APhA DrugInfoLine

›› Extended-duration enoxaparin thromboprophylaxis beneficial for some acutely ill medical patients – In a recent trial, extending enoxaparin prophylaxis for an additional 28 days after an initial 10-day course of therapy reduced the incidence of VTE. However, this beneficial effect was only seen in subgroups of patients with level 1 immobility, those older than 75 years, and women. Extended-duration enoxaparin was also associated with an increased risk of major bleeding events.

›› Delipidated HDL for acute coronary syndrome – In a first-in-man study, serial autologous delipidated HDL plasma infusions were clinically feasible and tolerated and safely increased HDL levels in patients suffering from acute coronary syndrome.

›› Meta-analysis: Statins do not decrease all-cause mortality – In a recent meta-analysis, statin therapy did not reduce all-cause mortality in high-risk patients who had no history of cardiovascular disease.

Journal of the American Pharmacists Association

›› Impact of drug importation on community pharmacy and patient care

›› Stars are aligning for public awareness of pharmacists as medication experts

›› Prescription drug product substitution decision support

In order to view JAPhA articles you must be an APhA member and login for access.

Journal of Pharmaceutical Sciences

›› Journal of Pharmaceutical Sciences Website

›› Review: The challenge of drying methods selection for protein pharmaceuticals: product quality implications

›› Research article: Decreased drug penetration in inflamed tissue related to changed mucosal metabolism in experimental colitis

›› Minireview: Implementing molecular connectivity theory, a basic tool in modeling drugs